Montine TJ - Search Results

1

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.

Li G, Sokal I, Quinn JF, Leverenz JB, Brodey M, Schellenberg GD, Kaye JA, Raskind MA, Zhang J, Peskind ER, Montine TJ. Li G, et al. Among authors: montine tj. Neurology. 2007 Aug 14;69(7):631-9. doi: 10.1212/01.wnl.0000267428.62582.aa. Neurology. 2007. PMID: 17698783

2

Increased CSF F2-isoprostane concentration in probable AD.

Montine TJ, Beal MF, Cudkowicz ME, O'Donnell H, Margolin RA, McFarland L, Bachrach AF, Zackert WE, Roberts LJ, Morrow JD. Montine TJ, et al. Neurology. 1999 Feb;52(3):562-5. doi: 10.1212/wnl.52.3.562. Neurology. 1999. PMID: 10025788

3

Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.

Zhang J, Graham DG, Montine TJ, Ho YS. Zhang J, et al. Among authors: montine tj. J Neuropathol Exp Neurol. 2000 Jan;59(1):53-61. doi: 10.1093/jnen/59.1.53. J Neuropathol Exp Neurol. 2000. PMID: 10744035

4

Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls.

Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, Quinn JF. Montine TJ, et al. Among authors: montine ks. Arch Pathol Lab Med. 2001 Apr;125(4):510-2. doi: 10.5858/2001-125-0510-CFATAF. Arch Pathol Lab Med. 2001. PMID: 11260625 Free article.

5

Lipid peroxidation in aging brain and Alzheimer's disease.

Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, Morrow JD. Montine TJ, et al. Free Radic Biol Med. 2002 Sep 1;33(5):620-6. doi: 10.1016/s0891-5849(02)00807-9. Free Radic Biol Med. 2002. PMID: 12208348 Review.

6

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD. Montine TJ, et al. Ann Neurol. 2002 Aug;52(2):175-9. doi: 10.1002/ana.10272. Ann Neurol. 2002. PMID: 12210787

7

Dopamine thioethers: formation in brain and neurotoxicity.

Montine KS, Sidell KR, Zhang J, Montine TJ. Montine KS, et al. Among authors: montine tj. Neurotox Res. 2002 Nov-Dec;4(7-8):663-669. doi: 10.1080/1029842021000045435. Neurotox Res. 2002. PMID: 12709304

8

Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.

Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Quinn JF, et al. Among authors: montine tj, montine ks. J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110. J Alzheimers Dis. 2004. PMID: 15004331

9

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ 2nd, Morrow JD, Montine TJ. Montine KS, et al. Among authors: montine tj. Chem Phys Lipids. 2004 Mar;128(1-2):117-24. doi: 10.1016/j.chemphyslip.2003.10.010. Chem Phys Lipids. 2004. PMID: 15037157 Review.

10

Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid.

Zhang J, Goodlett DR, Peskind ER, Quinn JF, Zhou Y, Wang Q, Pan C, Yi E, Eng J, Aebersold RH, Montine TJ. Zhang J, et al. Among authors: montine tj. Neurobiol Aging. 2005 Feb;26(2):207-27. doi: 10.1016/j.neurobiolaging.2004.03.012. Neurobiol Aging. 2005. PMID: 15582749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

538 results

Search Page